OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
3.120
+0.170 (5.76%)
At close: Jan 21, 2025, 4:00 PM
3.150
+0.030 (0.96%)
After-hours: Jan 21, 2025, 7:51 PM EST
OS Therapies Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
66.26M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionOSTX News
- 5 days ago - OS Therapies: A Cheap Mid-Stage Biotech Carrying Listeria-Based Immunotherapy - Seeking Alpha
- 6 days ago - Why Is Pediatric-Cancer Focused OS Therapies Stock Trading Higher On Wednesday? - Benzinga
- 6 days ago - OS Therapies Announces Phase 2b Clinical Trial of OST-HER2 Achieves Primary Endpoint with Statistical Significance in the Prevention of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma - Business Wire
- 19 days ago - OS Therapies to Attend the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 21 days ago - OS Therapies Announces Closing of $6 Million Private Placement - Business Wire
- 26 days ago - OS Therapies Partners with B2i Digital to Engage with Biotech Investors Online - Business Wire
- 4 weeks ago - OS Therapies Announces Pricing of $6 Million Private Placement - Business Wire
- 2 months ago - OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire